[go: up one dir, main page]

NO932057L - Ny dopamin-menneske-reseptor og dens anvendelser - Google Patents

Ny dopamin-menneske-reseptor og dens anvendelser

Info

Publication number
NO932057L
NO932057L NO93932057A NO932057A NO932057L NO 932057 L NO932057 L NO 932057L NO 93932057 A NO93932057 A NO 93932057A NO 932057 A NO932057 A NO 932057A NO 932057 L NO932057 L NO 932057L
Authority
NO
Norway
Prior art keywords
dopamin
human
applications
new
human receptor
Prior art date
Application number
NO93932057A
Other languages
English (en)
Other versions
NO311363B1 (no
NO932057D0 (no
Inventor
Olivier Civelli
Hubert Van Tol
Original Assignee
Oregon Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon Higher Education filed Critical Oregon Higher Education
Publication of NO932057D0 publication Critical patent/NO932057D0/no
Publication of NO932057L publication Critical patent/NO932057L/no
Publication of NO311363B1 publication Critical patent/NO311363B1/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406Neurotransmitters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406Neurotransmitters
    • G01N33/9413Dopamine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO19932057A 1990-12-07 1993-06-04 DNA-sekvens som koder for en dopamin-menneske-reseptor-D4, homogen sammensetning inneholdende reseptoren, anvendelse avnukleotidsekvensen, samt ekspresjonsvektor og cellekulturomfattende nukleotidsekvensen og anvendelse av ekspresjonsve NO311363B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/626,618 US5422265A (en) 1990-12-07 1990-12-07 DNA sequence for the human dopamine receptor D4 and expression thereof in mammalian cells
PCT/US1991/009308 WO1992010571A1 (en) 1990-12-07 1991-12-06 Human dopamine d4 receptor and its uses

Publications (3)

Publication Number Publication Date
NO932057D0 NO932057D0 (no) 1993-06-04
NO932057L true NO932057L (no) 1993-08-09
NO311363B1 NO311363B1 (no) 2001-11-19

Family

ID=24511138

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19932057A NO311363B1 (no) 1990-12-07 1993-06-04 DNA-sekvens som koder for en dopamin-menneske-reseptor-D4, homogen sammensetning inneholdende reseptoren, anvendelse avnukleotidsekvensen, samt ekspresjonsvektor og cellekulturomfattende nukleotidsekvensen og anvendelse av ekspresjonsve

Country Status (11)

Country Link
US (2) US5422265A (no)
EP (1) EP0574406B1 (no)
JP (1) JP2966093B2 (no)
AT (1) ATE196925T1 (no)
AU (1) AU652211B2 (no)
CA (1) CA2097698C (no)
DE (1) DE69132447T2 (no)
DK (1) DK0574406T3 (no)
FI (1) FI932573L (no)
NO (1) NO311363B1 (no)
WO (1) WO1992010571A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277591B1 (en) 1988-11-18 2001-08-21 Oregon Health Science University Dopamine receptors and genes
US5569601A (en) * 1990-12-07 1996-10-29 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Human dopamine receptor and its uses
EP0625990B1 (en) * 1991-10-16 1998-07-29 Chiron Corporation Glycoprotein complexes and glycoproteins
US5766948A (en) * 1993-01-06 1998-06-16 The Regents Of The University Of California Method for production of neuroblasts
US6486310B1 (en) * 1993-01-28 2002-11-26 Washington University Gene encoding the rat dopamine D4 receptor
US5576319A (en) * 1993-03-01 1996-11-19 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
SK106395A3 (en) * 1993-03-01 1995-12-06 Merck Sharp & Dohme Treating and treatment or prevention of mental diseases
US5622950A (en) * 1993-03-01 1997-04-22 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
US5468615A (en) * 1993-07-01 1995-11-21 The Upjohn Company Binding assay employing a synthetic gene for D4 dopamine receptors
WO1995009237A2 (en) * 1993-09-28 1995-04-06 Allelix Biopharmaceuticals Inc. Expression of human d4 dopamine receptors in stable cell lines
US5994503A (en) * 1995-03-27 1999-11-30 Yale University Nucleotide and protein sequences of lats genes and methods based thereon
US6531314B1 (en) * 1996-12-10 2003-03-11 Merck & Co., Inc. Growth hormone secretagogue receptor family
ATE438717T1 (de) * 1996-06-05 2009-08-15 Novartis Vaccines & Diagnostic Dp-75 kodierende dna und verfahren zu ihrer verwendung
AUPO427596A0 (en) * 1996-12-20 1997-01-23 Cooperative Research Centre For Tropical Plant Pathology Anti-microbial protein
WO2000009538A2 (en) 1998-08-10 2000-02-24 Merck & Co., Inc. Canine growth hormone secretagogue receptor
US6783973B1 (en) 2000-09-12 2004-08-31 Oregon Health & Science University Mammalian catecholamine receptor genes and uses
US7381542B2 (en) * 2001-07-09 2008-06-03 Oregon Health & Science University Nucleic acids encoding a biogenic amine receptor
WO2006116874A1 (en) * 2005-05-05 2006-11-09 Centre For Addiction And Mental Health Compositions and methods for modulating dopamine neurotransmission
WO2009149560A1 (en) * 2008-06-12 2009-12-17 Centre For Addiction And Mental Health Compositions and methods for modulating d1-d2 dopamine receptor interaction and function

Also Published As

Publication number Publication date
AU652211B2 (en) 1994-08-18
US5594108A (en) 1997-01-14
DE69132447T2 (de) 2001-03-08
DE69132447D1 (de) 2000-11-16
EP0574406B1 (en) 2000-10-11
CA2097698C (en) 1999-06-01
JP2966093B2 (ja) 1999-10-25
WO1992010571A1 (en) 1992-06-25
EP0574406A1 (en) 1993-12-22
CA2097698A1 (en) 1992-06-08
FI932573A7 (fi) 1993-07-09
FI932573L (fi) 1993-07-09
ATE196925T1 (de) 2000-10-15
US5422265A (en) 1995-06-06
FI932573A0 (fi) 1993-06-04
DK0574406T3 (da) 2000-11-13
AU9140391A (en) 1992-07-08
JPH06503958A (ja) 1994-05-12
NO311363B1 (no) 2001-11-19
NO932057D0 (no) 1993-06-04

Similar Documents

Publication Publication Date Title
NO932057L (no) Ny dopamin-menneske-reseptor og dens anvendelser
WO1994003602A3 (en) A novel human dopamine receptor and its uses
NO943775L (no) Melanocyt stimulerende hormon reseptor og anvendelse derav
WO1995006743A3 (en) Methods and compositions for the large scale production of recombinant adeno-associated virus
HUP9902310A2 (hu) Komplementer adenovírus-vektorrendszerek és sejtvonalak
BR0009392A (pt) Polipeptìdeo, sequência de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, métodos para produzir uma sequência de ácido nucleico mutante e para produzir um polipeptìdeo, mutante de um polipeptìdeo com atividade de alafa-amilase, e, uso do polipeptìdeo ou variante
DK1792982T3 (da) Codon-optimeret phosphatase og ekspression heraf i gær
PT728214E (pt) Linhas celulares estaveis capazes de expressar o gene de replicacao do virus adeno-associado
AU4241697A (en) Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
EP0232112A3 (en) Recombinant protein complex having human factor viii:c activity its production and use
DE3750125D1 (de) Biologische eindämmung.
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
IE801137L (en) Dna transfer vector
DK0856581T3 (da) Stabilt transficerede cellelinjer, der udtrykker GABA-A-receptorer
DK0811071T3 (da) Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner
DK109180A (da) Peptider med ubiquitin-lignende aktivitet og fremgangsmaade til fremstilling deraf
GB9919409D0 (en) Baculovirus expression system
CA2133845A1 (en) Adrenocorticotrophic hormone receptor and uses
HUP9801438A2 (hu) Növényekben előállított rekombináns preduodenális lipázok és polipeptid-származékaik, előállításuk és alkalmazásuk
AU1242188A (en) Isolation of single chain proteins with fsh suppressing activity from follicular fluid
DE3577994D1 (de) Vergroessernde virale dna-segmente.
DK1196560T3 (da) Neurotrofisk faktor receptor GFR-alfa-4
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
HU9500619D0 (en) Cloning and expression of b-app-c100 receptor
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes